China’s First ADC Secures Domestic Approval

Gastric Cancer Nod

 
• By Dexter Jie Yan

RemeGen’s second approval after a green light for its lupus drug signals accelerating approvals for domestically-developed antibodies in China.

RemeGene a lone player in China market
China’s First ADC Reaches Commercial Start Line • Source: Alamy

More from China

More from Focus On Asia